Clinical Trial Update: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports completion of a Phase 2/Phase 3 study evaluating Antaitavir Hasophate capsules in combination with Yiqibuvir tablets for chronic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Antaitavir Hasophate Capsules
• Yiqibuvir Tablets

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic HCV Infection | Phase 2, Phase 3 | Status: COMPLETED